Barclays
SRTS icon

Barclays’s Sensus Healthcare SRTS Stock Holding History

Barclays’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.41K Buy
2,786
+48
+2% +$168 ﹤0.01% 4716
2026
Q1 		$10.9K Hold
2,738
– – ﹤0.01% 4688
2025
Q4 		$10.9K Hold
2,738
– – ﹤0.01% 4927
2025
Q3 		$8.6K Hold
2,738
– – ﹤0.01% 5033
2025
Q2 		$13K Buy
2,738
+869
+46% +$4.07K ﹤0.01% 4896
2025
Q1 		$8.84K Sell
1,869
-3,197
-63% -$18.6K ﹤0.01% 4879
2024
Q4 		$35.1K Buy
+5,066
New +$37.1K ﹤0.01% 4829
2023
Q2 		– Sell
-2,379
Closed -$12.4K – 5052
2023
Q1 		$12.4K Sell
2,379
-3,940
-62% -$28.3K ﹤0.01% 4723
2022
Q4 		$46.9K Buy
6,319
+5,547
+719% +$50K ﹤0.01% 4574
2022
Q3 		$10K Buy
+772
New +$9.22K ﹤0.01% 4314
2018
Q4 		– Sell
-11
Closed – – 7304
2018
Q3 		$0 Buy
+11
New +$80 ﹤0.01% 7373

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Barclays's SRTS Position: Q2 2026 in Review

Barclays increased its Sensus Healthcare (SRTS) stake by 1.8% in Q2 2026, buying an estimated $168 and bringing the position to 2,786 shares worth $8.41K. The position accounts for ﹤0.01% of the portfolio, ranked #4716.

Barclays first reported a position in SRTS in Q3 2018 and has held it in 11 quarters since. The position peaked at $46.9K in Q4 2022. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Barclays held 2,786 shares of Sensus Healthcare worth $8.41K as of Q2 2026.
  • Barclays bought 48 Sensus Healthcare shares in Q2 2026, an estimated $168.
  • Sensus Healthcare made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4716 holding.
  • Barclays first reported a position in Sensus Healthcare in Q3 2018 and has held it in 11 quarters since.
  • Barclays's Sensus Healthcare position peaked at $46.9K in Q4 2022.
  • 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.